Article info

Download PDFPDF

Original research
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma

Authors

  1. Correspondence to Dr Eric Deutsch; eric.deutsch{at}gustaveroussy.fr
View Full Text

Citation

Boutros C, Chaput-Gras N, Lanoy E, et al
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma

Publication history

  • Accepted June 18, 2020
  • First published August 20, 2020.
Online issue publication 
August 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.